ERBB2 and neoplasm: Treatment of cells with increased concentration of nanoparticle resulted in a decrease in HER2 expression levels in a dose-dependent manner (Supplementary Figure S4B), indicating that nanoparticles can effectively deliver miR-489 into tumor cells.